SEC Form 4
Haemonetics Corporation (HAE) insider trading
In the 12 months to Oct 24, 2026, one HAE insider reported open-market purchases of $98.8K across 1 filing; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $98.8K
- 1 filing · Mark W. Kroll, Director
Who traded HAE, and when
- Purchase
HAE daily close from Oct 24, 2025 to Oct 23, 2026, between $49.44 and $122.06, last $118.51. 0 sale and 1 purchase filings by 1 insider, marked at their filing dates. Mark W. Kroll, Director: bought $98.8K across 1 filing, first filed Nov 12, 2025, last Nov 12, 2025.
Largest mark · tap a row for others
Mark W. Kroll · Director
Purchase $98,784
1,400 shares at $70.56 avg
Filed Nov 12, 2025 · traded Nov 10
Close on filing date $73.12
Mark W. Kroll · Director
Director
$98.8K boughtHas the Haemonetics Corporation's CEO sold stock?
No. Christopher Simon (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Mark W. Kroll | Director | — | $98.8K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Mark W. Kroll Director | Purchase | 1,400 | $70.56 | $98.8K | 24,757 |
GET /stocks/filings/vX/form-4?tickers=HAE&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"HAE"
],
"issuer_cik": "0000313143",
"owner_cik": "0001259254",
"accession_number": "0000313143-25-000078",
"form_type": "4",
"filing_date": "2025-11-12",
"period_of_report": "2025-11-10",
"issuer_name": "HAEMONETICS CORP",
"issuer_trading_symbol": "HAE",
"owner_name": "KROLL MARK W",
"is_director": true,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2025-11-10",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 1400,
"transaction_price_per_share": 70.56,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 24757,
"transaction_value": 98784,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This number includes unvested restricted stock units previously reported."
}
]
}
]
}
// trimmed to 1 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 26 records
- Tax withholding11 records
- Grants and awards15 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for HAE every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.